Clinical Trial Update: Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating mesenchymal stromal cells versus best available therapy for steroid-refractory acute graft-versus-host disease, with recruitment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: medac GmbH | Conditions: Steroid-refractory Acute Graft-versus-host Disease | Phase 3 | Status: RECRUITING